Publicação
Functional mobility in Parkinson’s disease
| datacite.subject.fos | Ciências Médicas::Medicina Básica | pt_PT |
| dc.contributor.advisor | Ferreira, Joaquim | |
| dc.contributor.advisor | Matias, Ricardo | |
| dc.contributor.author | Bouça-Machado, Raquel | |
| dc.date.accessioned | 2023-06-01T14:06:40Z | |
| dc.date.available | 2023-06-01T14:06:40Z | |
| dc.date.issued | 2021-09 | |
| dc.date.submitted | 2021-04 | |
| dc.description.abstract | Introduction: Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1% of the world population over the age of 60. The presence of a large and heterogeneous spectrum of motor and non-motor symptoms, some resistant to levodopa therapy, is usually a major source of disability that affects patients’ daily activities and social participation. Functional mobility (FM) is an outcome that merges the concepts of function with mobility, autonomy, and the accomplishment of daily tasks in different environments. Its use in PD studies is common. However, several aspects associated with its application in PD remain to be defined, hampering a wider use of the concept in clinical practice and the comparison of clinical study results. Aim: This thesis aimed to provide evidence on the appropriateness of the concept of FM in the PD field. A two-fold approach was used to this end: 1) To investigate the clinical and research applicability of the concept of FM in PD; 2) To identify the most suitable clinical and technological outcome measures for evaluating the response of PD patients’ FM to a therapeutic intervention. Methods: A narrative review using the framework of the International Classification of Functioning, Disability, and Health (ICF) was performed to explore the concept of FM when applied to PD. This first study aimed to provide a better understanding of the interaction between PD symptoms, FM, and patients’ daily activities and social participation. To identify and recommend the most suitable outcome measures to assess FM in PD, a systematic review was conducted using the CENTRAL, MEDLINE, Embase, and PEDro databases, from their inception to January 2019. During this review, we also explored the different definitions of FM present in the literature, proposing the one we believed should be established as the definition of FM in the PD field. We then conducted a focus group to explore PD patients' and health professionals’ perspectives on the proposed definition. Part of the scope of the focus group was also to investigate the impact of FM problems on patients’ daily living and the strategies used to deal with this. The study included four focus groups, two with patients (early and advanced disease stages), and two with health professionals (neurologists and physiotherapists). A second systematic review using the CENTRAL, MEDLINE, Embase, and PEDro databases, from their inception to September 2019, was performed to summarize and critically appraise the published evidence on PD spatiotemporal gait parameters. Finally, a pragmatic clinical study was conducted to identify the clinical and technological outcome measures that better predict changes in FM, when patients are submitted to a specialized multidisciplinary program for PD. Results: All the definitions found in an open search of the literature on the FM concept included three key aspects: gait, balance, and transfers. All participants in the focus group study were able to present a spontaneous definition of FM that matched the one used by the authors. All also agreed that FM reflects the difficulties of PD patients in daily life activities. Early-stage PD patients mentioned needing more time to complete their usual tasks, while advanced-stage PD patients considered FM limitations as the main limiting factor of daily activities, especially in medication “OFF” periods. Physiotherapists maintained that the management of PD FM limitations should be a joint work of the multidisciplinary team. For neurologists, FM may better express patients’ perception of their overall health status and may help to adopt a more patient-centered approach. Of the 95 studies included in the systematic review aiming to appraise the outcome measures that have been used to assess FM in PD patients, only one defined the concept of FM. The most frequent terms used as synonyms of FM were mobility, mobility in association with functional activities/performance, motor function, gait-related activity, or balance. In the literature, the Timed Up and Go (TUG) test was the most frequently reported tool used as a single instrument to assess FM in PD. The changes from baseline in the TUG Cognitive test, step length, and free-living step time asymmetry were identified as the best predictors of TUG changes. Conclusion: The information generated by the different studies included in this thesis revealed FM as a useful concept to be adopted in the PD field. FM was shown to be a meaningful outcome (for patients and health professionals), easy to measure, and able to provide more global and ecological information on patients’ daily living performances. Our results support the use of FM for PD assessment and free-living monitoring, as a way to better understand and address patients’ needs. The changes in the TUG Cognitive test, the supervised step length, and the free-living step time asymmetry seem the most suitable outcomes to measure an effect in FM. Future research should focus on determining the severity cut-off for FM changes, the minimal clinical important difference (MCID) for each of these outcome measures and resolve the current obstacles to the widespread use of technological assessments in PD clinical practice and research. | pt_PT |
| dc.identifier.tid | 101639600 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10451/57777 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | Instrumentos de avalição na doença de Parkinson: medidas objectivas e sistemas terapêuticos de sistema fechado | |
| dc.subject | Mobilidade Funcional | pt_PT |
| dc.subject | Doença de Parkinson | pt_PT |
| dc.subject | Instrumentos de Medida | pt_PT |
| dc.subject | Tecnologia | pt_PT |
| dc.subject | sensores | pt_PT |
| dc.subject | Functional Mobility | pt_PT |
| dc.subject | Parkinson’s disease | pt_PT |
| dc.subject | Outcome measures | pt_PT |
| dc.subject | Technology | pt_PT |
| dc.subject | sensors | pt_PT |
| dc.title | Functional mobility in Parkinson’s disease | pt_PT |
| dc.type | doctoral thesis | |
| dspace.entity.type | Publication | |
| oaire.awardNumber | SFRH/BD/120773/2016 | |
| oaire.awardTitle | Instrumentos de avalição na doença de Parkinson: medidas objectivas e sistemas terapêuticos de sistema fechado | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F120773%2F2016/PT | |
| oaire.fundingStream | OE | |
| person.familyName | Bouça-Machado | |
| person.givenName | Raquel | |
| person.identifier | 504427 | |
| person.identifier.ciencia-id | D718-771B-C6AA | |
| person.identifier.orcid | 0000-0003-3756-2763 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | doctoralThesis | pt_PT |
| relation.isAuthorOfPublication | 172e72bb-a6e7-4334-9366-5d0268b6292e | |
| relation.isAuthorOfPublication.latestForDiscovery | 172e72bb-a6e7-4334-9366-5d0268b6292e | |
| relation.isProjectOfPublication | 99d75144-8290-4727-81a5-d1d680944d48 | |
| relation.isProjectOfPublication.latestForDiscovery | 99d75144-8290-4727-81a5-d1d680944d48 | |
| thesis.degree.name | Tese de doutoramento, Ciências Biomédicas (Neurociências), Universidade de Lisboa, Faculdade de Medicina, 2021 | pt_PT |